HYDEAL CYST Trademark

Trademark Overview


On Wednesday, October 28, 2020, a trademark application was filed for HYDEAL CYST with the United States Patent and Trademark Office. The USPTO has given the HYDEAL CYST trademark a serial number of 79310437. The federal status of this trademark filing is REGISTERED as of Tuesday, June 13, 2023. This trademark is owned by FIDIA FARMACEUTICI S.p.A.. The HYDEAL CYST trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations for use in treating gynecological and urological diseases and disorders; pharmaceutical preparations for treating ailments caused by radiation or chemotherapy; medical preparations for use in treating gynecological and urological diseases and disorders; medical preparations for treating ailments caused by radiation or chemotherapy; medicinal preparations for use in treating gynecological and urological diseases and disorders; medicinal preparations for treating ailments caused by radiation or chemotherapy; pharmaceutical substances for use in treating gynecological and urological diseases and disorders; medicated food supplements

syringes for injections; apparatus for irrigation of liquids for medical use; syringes and cannulas for medical use
hydeal cyst

General Information


Serial Number79310437
Word MarkHYDEAL CYST
Filing DateWednesday, October 28, 2020
Status700 - REGISTERED
Status DateTuesday, June 13, 2023
Registration Number7077390
Registration DateTuesday, June 13, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 28, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for use in treating gynecological and urological diseases and disorders; pharmaceutical preparations for treating ailments caused by radiation or chemotherapy; medical preparations for use in treating gynecological and urological diseases and disorders; medical preparations for treating ailments caused by radiation or chemotherapy; medicinal preparations for use in treating gynecological and urological diseases and disorders; medicinal preparations for treating ailments caused by radiation or chemotherapy; pharmaceutical substances for use in treating gynecological and urological diseases and disorders; medicated food supplements
Goods and Servicessyringes for injections; apparatus for irrigation of liquids for medical use; syringes and cannulas for medical use
Disclaimer with Predetermined Text"CYST"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 14, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, May 14, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFIDIA FARMACEUTICI S.p.A.
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressIT

Party NameFIDIA FARMACEUTICI S.p.A.
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressIT

Party NameFIDIA FARMACEUTICI S.p.A.
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressIT

Trademark Events


Event DateEvent Description
Monday, October 9, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, September 14, 2023FINAL DISPOSITION NOTICE SENT TO IB
Thursday, September 14, 2023FINAL DISPOSITION PROCESSED
Wednesday, September 13, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 13, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 13, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, March 29, 2023NOTIFICATION PROCESSED BY IB
Tuesday, March 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 28, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 8, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 8, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 21, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, February 18, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 17, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 17, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, October 31, 2022NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, October 12, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 12, 2022NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Friday, August 26, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, August 26, 2022FINAL REFUSAL E-MAILED
Friday, August 26, 2022FINAL REFUSAL WRITTEN
Wednesday, August 3, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 2, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 2, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 2, 2022NON-FINAL ACTION E-MAILED
Wednesday, February 2, 2022NON-FINAL ACTION WRITTEN
Thursday, December 2, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 1, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 1, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, June 27, 2021REFUSAL PROCESSED BY IB
Tuesday, June 1, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, June 1, 2021REFUSAL PROCESSED BY MPU
Thursday, May 27, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, May 26, 2021NON-FINAL ACTION WRITTEN
Tuesday, May 18, 2021APPLICATION FILING RECEIPT MAILED
Friday, May 14, 2021ASSIGNED TO EXAMINER
Friday, May 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 13, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Saturday, May 8, 2021SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB